300 related articles for article (PubMed ID: 31502365)
1. The frequency of circulating integrin α4β7
Akter S; Jeverstam F; Lundgren A; Magnusson MK; Walduck A; Qadri F; Bhuiyan TR; Raghavan S
Helicobacter; 2019 Dec; 24(6):e12658. PubMed ID: 31502365
[TBL] [Abstract][Full Text] [Related]
2. Induction of mucosal immune responses against Helicobacter pylori infection after sublingual and intragastric route of immunization.
Sjökvist Ottsjö L; Jeverstam F; Yrlid L; Wenzel AU; Walduck AK; Raghavan S
Immunology; 2017 Feb; 150(2):172-183. PubMed ID: 27676456
[TBL] [Abstract][Full Text] [Related]
3. Mucosal vaccination increases local chemokine production attracting immune cells to the stomach mucosa of Helicobacter pylori infected mice.
Flach CF; Mozer M; Sundquist M; Holmgren J; Raghavan S
Vaccine; 2012 Feb; 30(9):1636-43. PubMed ID: 22230589
[TBL] [Abstract][Full Text] [Related]
4. Mucosal immunization with a urease B DNA vaccine induces innate and cellular immune responses against Helicobacter pylori.
Hatzifoti C; Roussel Y; Harris AG; Wren BW; Morrow JW; Bajaj-Elliott M
Helicobacter; 2006 Apr; 11(2):113-22. PubMed ID: 16579841
[TBL] [Abstract][Full Text] [Related]
5. Vaccine-induced immunity against Helicobacter pylori in the absence of IL-17A.
DeLyria ES; Nedrud JG; Ernst PB; Alam MS; Redline RW; Ding H; Czinn SJ; Xu J; Blanchard TG
Helicobacter; 2011 Jun; 16(3):169-78. PubMed ID: 21585602
[TBL] [Abstract][Full Text] [Related]
6. Sublingual immunization protects against Helicobacter pylori infection and induces T and B cell responses in the stomach.
Raghavan S; Ostberg AK; Flach CF; Ekman A; Blomquist M; Czerkinsky C; Holmgren J
Infect Immun; 2010 Oct; 78(10):4251-60. PubMed ID: 20696831
[TBL] [Abstract][Full Text] [Related]
7. A double mutant heat-labile toxin from Escherichia coli, LT(R192G/L211A), is an effective mucosal adjuvant for vaccination against Helicobacter pylori infection.
Sjökvist Ottsjö L; Flach CF; Clements J; Holmgren J; Raghavan S
Infect Immun; 2013 May; 81(5):1532-40. PubMed ID: 23439305
[TBL] [Abstract][Full Text] [Related]
8. Local recall responses in the stomach involving reduced regulation and expanded help mediate vaccine-induced protection against Helicobacter pylori in mice.
Becher D; Deutscher ME; Simpfendorfer KR; Wijburg OL; Pederson JS; Lew AM; Strugnell RA; Walduck AK
Eur J Immunol; 2010 Oct; 40(10):2778-90. PubMed ID: 21038469
[TBL] [Abstract][Full Text] [Related]
9. Mucosal immune responses are related to reduction of bacterial colonization in the stomach after therapeutic Helicobacter pylori immunization in mice.
Nyström J; Raghavan S; Svennerholm AM
Microbes Infect; 2006 Feb; 8(2):442-9. PubMed ID: 16243563
[TBL] [Abstract][Full Text] [Related]
10. Homing commitment of lymphocytes activated in the human gastric and intestinal mucosa.
Quiding-Järbrink M; Ahlstedt I; Lindholm C; Johansson EL; Lönroth H
Gut; 2001 Oct; 49(4):519-25. PubMed ID: 11559649
[TBL] [Abstract][Full Text] [Related]
11. Vaccine-induced gastric CD4
Xu N; Ruan G; Liu W; Hu C; Huang A; Zeng Z; Luo S; Zhang Z; Fan M; Ye F; Xi T; Xing Y
Helicobacter; 2019 Oct; 24(5):e12652. PubMed ID: 31414552
[TBL] [Abstract][Full Text] [Related]
12. Preclinical immunogenicity and protective efficacy of an oral Helicobacter pylori inactivated whole cell vaccine and multiple mutant cholera toxin: A novel and non-toxic mucosal adjuvant.
Holmgren J; Nordqvist S; Blomquist M; Jeverstam F; Lebens M; Raghavan S
Vaccine; 2018 Oct; 36(41):6223-6230. PubMed ID: 30119923
[TBL] [Abstract][Full Text] [Related]
13. Immunization of mice with urease vaccine affords protection against Helicobacter pylori infection in the absence of antibodies and is mediated by MHC class II-restricted responses.
Ermak TH; Giannasca PJ; Nichols R; Myers GA; Nedrud J; Weltzin R; Lee CK; Kleanthous H; Monath TP
J Exp Med; 1998 Dec; 188(12):2277-88. PubMed ID: 9858514
[TBL] [Abstract][Full Text] [Related]
14. Helicobacter pylori infection in immunized mice lacking major histocompatibility complex class I and class II functions.
Pappo J; Torrey D; Castriotta L; Savinainen A; Kabok Z; Ibraghimov A
Infect Immun; 1999 Jan; 67(1):337-41. PubMed ID: 9864234
[TBL] [Abstract][Full Text] [Related]
15. Defining the Roles of IFN-γ and IL-17A in Inflammation and Protection against Helicobacter pylori Infection.
Sjökvist Ottsjö L; Flach CF; Nilsson S; Malefyt Rde W; Walduck AK; Raghavan S
PLoS One; 2015; 10(7):e0131444. PubMed ID: 26168305
[TBL] [Abstract][Full Text] [Related]
16. Host Nonresponsiveness Does not Interfere With Vaccine-Mediated Protection Against Gastric Helicobacter Infection.
Harbour SN; Mitchell HM; Sutton P
Helicobacter; 2015 Jun; 20(3):217-22. PubMed ID: 25683672
[TBL] [Abstract][Full Text] [Related]
17. [The role of local immune response in gastric mucosa in the protection induced by Helicobacter pylori vaccine with chitosan as adjuvant].
Xie Y; Gong YF; Zhou NJ; Chen J; Zhou XJ; Lü NH; Wang CW
Zhonghua Yi Xue Za Zhi; 2005 Sep; 85(37):2629-35. PubMed ID: 16321324
[TBL] [Abstract][Full Text] [Related]
18. The C-terminally encoded, MHC class II-restricted T cell antigenicity of the Helicobacter pylori virulence factor CagA promotes gastric preneoplasia.
Arnold IC; Hitzler I; Engler D; Oertli M; Agger EM; Müller A
J Immunol; 2011 Jun; 186(11):6165-72. PubMed ID: 21518972
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of a new tumor necrosis factor-alpha-inducing membrane protein of Helicobacter pylori as a prophylactic vaccine antigen.
Inoue K; Shiota S; Yamada K; Gotoh K; Suganuma M; Fujioka T; Ahmed K; Iha H; Nishizono A
Helicobacter; 2009 Oct; 14(5):135-43. PubMed ID: 19751439
[TBL] [Abstract][Full Text] [Related]
20. Proinflammatory cytokine gene expression in the stomach correlates with vaccine-induced protection against Helicobacter pylori infection in mice: an important role for interleukin-17 during the effector phase.
Flach CF; Östberg AK; Nilsson AT; Malefyt Rde W; Raghavan S
Infect Immun; 2011 Feb; 79(2):879-86. PubMed ID: 21078851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
